Cite

HARVARD Citation

    Ritzel, R. et al. (2022). IDF21-0686 Indirect treatment comparison of efficacy and safety of insulin glargine 300 U/mL with once-daily-insulin premix in T2DM. Diabetes research and clinical practice. p. . [Online]. 
  
Back to record